Aviex Technologies, LLC was founded
to develop a novel, rapid response vaccine platform for infectious diseases.


Aviex's mission is to develop more potent unique and effective orally administered vaccines by employing an inventive vaccine platform delivery system.

The Aviex Platform is designed to deliver a variety of vaccines that address infectious diseases caused by bacterial, parasitic and viral pathogens for both human and animal health. The company goal is to develop an ongoing pipeline of vaccine products utilizing the enhanced YS1646 vector.